{"id":"https://openalex.org/W4283658561","doi":"https://doi.org/10.1016/s2352-3026(22)00169-7","title":"Easy does it! New EZH2 inhibitor SHR2554 is safe and active in relapsed or refractory lymphoma","display_name":"Easy does it! New EZH2 inhibitor SHR2554 is safe and active in relapsed or refractory lymphoma","publication_year":2022,"publication_date":"2022-06-27","ids":{"openalex":"https://openalex.org/W4283658561","doi":"https://doi.org/10.1016/s2352-3026(22)00169-7","pmid":"https://pubmed.ncbi.nlm.nih.gov/35772421"},"language":"en","primary_location":{"id":"doi:10.1016/s2352-3026(22)00169-7","doi":"https://doi.org/10.1016/s2352-3026(22)00169-7","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s2352-3026(22)00169-7","pdf_url":null,"source":{"id":"https://openalex.org/S2531671668","display_name":"The Lancet Haematology","issn_l":"2352-3026","issn":["2352-3026","2451-9960"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet Haematology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110243703","display_name":"Yun Kyoung Ryu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yun Kyoung Ryu","raw_affiliation_strings":["Division of Hematology-Oncology, Columbia University Irving Medical Center, New York, NY 10032, USA; Department of Medicine, Columbia University Irving Medical Center, New York, NY 10032, USA","Department of Medicine, Columbia University Irving Medical Center, New York, NY 10032, USA","Division of Hematology-Oncology, Columbia University Irving Medical Center, New York, NY 10032, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology-Oncology, Columbia University Irving Medical Center, New York, NY 10032, USA; Department of Medicine, Columbia University Irving Medical Center, New York, NY 10032, USA","institution_ids":["https://openalex.org/I2799503643"]},{"raw_affiliation_string":"Department of Medicine, Columbia University Irving Medical Center, New York, NY 10032, USA","institution_ids":["https://openalex.org/I2799503643"]},{"raw_affiliation_string":"Division of Hematology-Oncology, Columbia University Irving Medical Center, New York, NY 10032, USA","institution_ids":["https://openalex.org/I2799503643"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5075692970","display_name":"Jennifer Effie Amengual","orcid":"https://orcid.org/0000-0003-4117-2469","observed_orcids":["https://orcid.org/0000-0003-4117-2469"]},"institutions":[{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jennifer E Amengual","raw_affiliation_strings":["Division of Hematology-Oncology, Columbia University Irving Medical Center, New York, NY 10032, USA; Department of Medicine, Columbia University Irving Medical Center, New York, NY 10032, USA. Electronic address: jea2149@cumc.columbia.edu","Department of Medicine, Columbia University Irving Medical Center, New York, NY 10032, USA","Division of Hematology-Oncology, Columbia University Irving Medical Center, New York, NY 10032, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology-Oncology, Columbia University Irving Medical Center, New York, NY 10032, USA; Department of Medicine, Columbia University Irving Medical Center, New York, NY 10032, USA. Electronic address: jea2149@cumc.columbia.edu","institution_ids":["https://openalex.org/I2799503643"]},{"raw_affiliation_string":"Department of Medicine, Columbia University Irving Medical Center, New York, NY 10032, USA","institution_ids":["https://openalex.org/I2799503643"]},{"raw_affiliation_string":"Division of Hematology-Oncology, Columbia University Irving Medical Center, New York, NY 10032, USA","institution_ids":["https://openalex.org/I2799503643"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5075692970"],"corresponding_institution_ids":["https://openalex.org/I2799503643"],"apc_list":{"value":6000,"currency":"USD","value_usd":6000},"apc_paid":null,"fwci":0.3329,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.53179008,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"9","issue":"7","first_page":"e463","last_page":"e465"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9854000210762024,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9854000210762024,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0071000000461936,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11811","display_name":"Cutaneous lymphoproliferative disorders research","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ezh2-inhibitors","display_name":"EZH2 inhibitors","score":0.9589999914169312},{"id":"https://openalex.org/keywords/relapsed-refractory-lymphoma","display_name":"relapsed/refractory lymphoma","score":0.9940000176429749},{"id":"https://openalex.org/keywords/mature-b-cell-lymphoma","display_name":"mature B-cell lymphoma","score":0.6869999766349792},{"id":"https://openalex.org/keywords/safety-profile","display_name":"safety profile","score":0.5540000200271606},{"id":"https://openalex.org/keywords/antitumour-activity","display_name":"antitumour activity","score":0.9200000166893005},{"id":"https://openalex.org/keywords/romidepsin","display_name":"romidepsin","score":0.781000018119812},{"id":"https://openalex.org/keywords/peripheral-t-cell-lymphoma","display_name":"peripheral T-cell lymphoma","score":0.8330000042915344},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.5329999923706055}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9232134819030762},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.7800822257995605},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.536992073059082},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.482340544462204},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.46480122208595276},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000071221","descriptor_name":"Enhancer of Zeste Homolog 2 Protein","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008223","descriptor_name":"Lymphoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008228","descriptor_name":"Lymphoma, Non-Hodgkin","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/s2352-3026(22)00169-7","doi":"https://doi.org/10.1016/s2352-3026(22)00169-7","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s2352-3026(22)00169-7","pdf_url":null,"source":{"id":"https://openalex.org/S2531671668","display_name":"The Lancet Haematology","issn_l":"2352-3026","issn":["2352-3026","2451-9960"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet Haematology","raw_type":"journal-article"},{"id":"pmid:35772421","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35772421","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet. Haematology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":11,"referenced_works":["https://openalex.org/W2010711123","https://openalex.org/W2024373518","https://openalex.org/W2042093631","https://openalex.org/W2936334155","https://openalex.org/W3092409743","https://openalex.org/W3092484545","https://openalex.org/W3158563222","https://openalex.org/W3214025529","https://openalex.org/W3217609143","https://openalex.org/W4283659271","https://openalex.org/W6803753271"],"related_works":["https://openalex.org/W4283659271","https://openalex.org/W4281664810","https://openalex.org/W4390674554","https://openalex.org/W4379980023","https://openalex.org/W3182442681","https://openalex.org/W3217609143","https://openalex.org/W2114594238","https://openalex.org/W4379283888","https://openalex.org/W2116068882","https://openalex.org/W2171321751"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-06-29T00:00:00"}